Tesamorelin Dosage

Medically reviewed by Drugs.com. Last updated on Aug 7, 2023.

Usual Adult Dose for Lipodystrophy

2 mg subcutaneously once a day

Comments:

• Long term cardiovascular safety and benefit have not been studied.
• Not indicated for weight loss (weight neutral effect).
• There are no data to support improved compliance with anti-retroviral therapies in HIV positive patients.

Use(s): Reduction of excess abdominal fat in HIV-infected patients with lipodystrophy

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Precautions

CONTRAINDICATIONS:

• Disruption of the hypothalamic-pituitary axis due to hypophysectomy, hypopituitarism, pituitary tumor/surgery, head irradiation, or head trauma
• Active malignancy (newly diagnosed or recurrent)
• Hypersensitivity to tesamorelin and/or mannitol (an excipient)
• Pregnancy

Safety and efficacy have not been established in patients younger than 18 years.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:

• Administer into abdominal skin subcutaneously, rotating sites.
• Do not inject into scar tissue, bruises, or the navel.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer